| Assessment of the appropriateness of antibiotic prescriptions for infection prophylaxis before dental procedures, 2011 to 2015 KJ Suda, GS Calip, J Zhou, S Rowan, AE Gross, RC Hershow, RI Perez, ... JAMA network open 2 (5), e193909-e193909, 2019 | 199 | 2019 |
| Association of insurance status and racial disparities with the detection of early-stage breast cancer NY Ko, S Hong, RA Winn, GS Calip JAMA oncology 6 (3), 385-392, 2020 | 182 | 2020 |
| Comparison of opioid prescribing by dentists in the United States and England KJ Suda, MJ Durkin, GS Calip, WF Gellad, H Kim, PB Lockhart, SA Rowan, ... JAMA network open 2 (5), e194303-e194303, 2019 | 108 | 2019 |
| Effect of treatment and mammography detection on breast cancer survival over time: 1990‐2007 HG Kaplan, JA Malmgren, MK Atwood, GS Calip Cancer 121 (15), 2553-2561, 2015 | 98 | 2015 |
| Metabolic syndrome and outcomes following early-stage breast cancer GS Calip, KE Malone, JR Gralow, A Stergachis, RA Hubbard, ... Breast cancer research and treatment 148, 363-377, 2014 | 93 | 2014 |
| Association of race/ethnicity and the 21-gene recurrence score with breast cancer–specific mortality among US women KF Hoskins, OC Danciu, NY Ko, GS Calip JAMA oncology 7 (3), 370-378, 2021 | 88 | 2021 |
| First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies S Dellicour, E Sevene, R McGready, H Tinto, D Mosha, C Manyando, ... PLoS medicine 14 (5), e1002290, 2017 | 88 | 2017 |
| Risk of amputations associated with SGLT2 inhibitors compared to DPP‐4 inhibitors: a propensity‐matched cohort study S Adimadhyam, TA Lee, GS Calip, DE Smith Marsh, BT Layden, ... Diabetes, Obesity and Metabolism 20 (12), 2792-2799, 2018 | 64 | 2018 |
| Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment GS Calip, RA Hubbard, A Stergachis, KE Malone, JR Gralow, ... Pharmacoepidemiology and drug safety 24 (1), 75-85, 2015 | 64 | 2015 |
| Tumor necrosis factor‐alpha inhibitors and risk of non‐Hodgkin lymphoma in a cohort of adults with rheumatologic conditions GS Calip, PR Patel, S Adimadhyam, S Xing, Z Wu, K Sweiss, ... International journal of cancer 143 (5), 1062-1071, 2018 | 63 | 2018 |
| Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions GS Calip, S Adimadhyam, S Xing, JC Rincon, WJ Lee, RH Anguiano Seminars in arthritis and rheumatism 47 (2), 157-164, 2017 | 63 | 2017 |
| Overprescribing of opioids to adults by dentists in the US, 2011–2015 KJ Suda, J Zhou, SA Rowan, JC McGregor, RI Perez, CT Evans, ... American journal of preventive medicine 58 (4), 473-486, 2020 | 60 | 2020 |
| Characterization of opioid use in sickle cell disease J Han, J Zhou, SL Saraf, VR Gordeuk, GS Calip Pharmacoepidemiology and drug safety 27 (5), 479-486, 2018 | 59 | 2018 |
| Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors GS Calip, JG Elmore, DM Boudreau Breast cancer research and treatment 161, 161-172, 2017 | 49 | 2017 |
| Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya S Dellicour, G Aol, P Ouma, N Yan, G Bigogo, MJ Hamel, DC Burton, ... BMJ open 6 (4), e011088, 2016 | 49 | 2016 |
| Changes in adherence to statins and subsequent lipid profiles during and following breast cancer treatment GS Calip, DM Boudreau, ET Loggers Breast cancer research and treatment 138, 225-233, 2013 | 47 | 2013 |
| Polypharmacy and adherence to adjuvant endocrine therapy for breast cancer GS Calip, S Xing, DH Jun, WJ Lee, KF Hoskins, NY Ko Journal of oncology practice 13 (5), e451-e462, 2017 | 44 | 2017 |
| Associations between diabetes medication use and risk of second breast cancer events and mortality GS Calip, O Yu, KF Hoskins, DM Boudreau Cancer Causes & Control 26, 1065-1077, 2015 | 42 | 2015 |
| Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial JM Schenk, GS Calip, CM Tangen, P Goodman, JK Parsons, ... American journal of epidemiology 176 (2), 156-163, 2012 | 42 | 2012 |
| Racial and ethnic inequities in US oncology clinical trial participation from 2017 to 2022 H Pittell, GS Calip, A Pierre, CA Ryals, I Altomare, TJ Royce, ... JAMA Network Open 6 (7), e2322515-e2322515, 2023 | 41 | 2023 |
